Drug Profile
SA 8443
Latest Information Update: 10 Jun 1998
Price :
$50
*
At a glance
- Originator Santen Pharmaceutical
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral hepatitis
Most Recent Events
- 10 Jun 1998 Discontinued-I for Viral hepatitis in Japan (Unknown route)
- 13 Oct 1995 New profile
- 13 Oct 1995 Phase-I clinical trials for Viral hepatitis in Japan (Unknown route)